Analysed REGENERATIVE MEDICAL TECHNOL (RMTG:OTCMKTS) News Sources
RMTG Subsidiary Cellgenic to Host Soft Opening of Advanced Cell Therapy Manufacturing Lab in Cancun During September ISSCA Global Summit
25-08-2025
yahoo.com
RMTG's ISSCA Regenerative Medicine Global Summit 2025 Concludes in Cancún with Full Attendance from 30+ Countries
08-10-2025
yahoo.com
RMTG Subsidiary CELLGENIC Expands into Dominican Republic with New Distribution Partnership
21-10-2025
yahoo.com
RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit
18-11-2025
yahoo.com
RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind
26-03-2026
yahoo.com
RMTG Surges 93% in Revenue, 87% in Gross Profit and 70% in Operating Income for Q1 2026 vs Q1 2025
10-06-2026
yahoo.com
Global Stem Cells Group (OTC:RMTG) Launches ISSCA Mobile App, Advancing Its Buildout of a Global Digital Ecosystem for Regenerative Medicine
17-06-2026
yahoo.com
What is the current price of REGENERATIVE MEDICAL TECHNOL (RMTG:OTCMKTS)?
The current price of REGENERATIVE MEDICAL TECHNOL (RMTG:OTCMKTS) is $0.0517.
REGENERATIVE MEDICAL TECHNOL (RMTG:OTCMKTS) absolute price change since previous trading day?
The absolute price change of REGENERATIVE MEDICAL TECHNOL (RMTG:OTCMKTS) since the previous trading day is $0.0217.
REGENERATIVE MEDICAL TECHNOL (RMTG:OTCMKTS) percentage price change since previous trading day?
The percentage price change of REGENERATIVE MEDICAL TECHNOL (RMTG:OTCMKTS) since the previous trading day is 72.3333%.
What is the most recent average sentiment score for REGENERATIVE MEDICAL TECHNOL (RMTG:OTCMKTS)?
The most recent average sentiment score for REGENERATIVE MEDICAL TECHNOL (RMTG:OTCMKTS) is 74 out of 100.
What is the most recent average sentiment for REGENERATIVE MEDICAL TECHNOL (RMTG:OTCMKTS)?
The most recent sentiment for REGENERATIVE MEDICAL TECHNOL (RMTG:OTCMKTS) is .
SEC-8K** Filing Available For REGENERATIVE MEDICAL TECHNOL (RMTG:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.